The Vita Coco Company Earnings Calls
| Release date | Jul 23, 2026 |
| EPS estimate | $0.556 |
| EPS actual | $0.82 |
| EPS Surprise | 47.48% |
| Revenue estimate | 210.643M |
| Revenue actual | 216.153M |
| Revenue Surprise | 2.62% |
| Release date | Apr 29, 2026 |
| EPS estimate | $0.340 |
| EPS actual | $0.500 |
| EPS Surprise | 47.06% |
| Revenue estimate | 148.387M |
| Revenue actual | 179.765M |
| Revenue Surprise | 21.15% |
| Release date | Feb 18, 2026 |
| EPS estimate | $0.130 |
| EPS actual | $0.0900 |
| EPS Surprise | -30.77% |
| Revenue estimate | 119.212M |
| Revenue actual | 127.787M |
| Revenue Surprise | 7.19% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.320 |
| EPS actual | $0.400 |
| EPS Surprise | 25.00% |
| Revenue estimate | 117.798M |
| Revenue actual | 182.313M |
| Revenue Surprise | 54.77% |
Last 4 Quarters for The Vita Coco Company
Below you can see how COCO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 29, 2025 |
| Price on release | $45.28 |
| EPS estimate | $0.320 |
| EPS actual | $0.400 |
| EPS surprise | 25.00% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $40.85 |
| Oct 24, 2025 | $39.67 |
| Oct 27, 2025 | $40.98 |
| Oct 28, 2025 | $42.24 |
| Oct 29, 2025 | $45.28 |
| Oct 30, 2025 | $42.61 |
| Oct 31, 2025 | $41.18 |
| Nov 03, 2025 | $40.82 |
| Nov 04, 2025 | $39.88 |
| 4 days before | 10.84% |
| 4 days after | -11.93% |
| On release day | -5.90% |
| Change in period | -2.37% |
| Release date | Feb 18, 2026 |
| Price on release | $50.06 |
| EPS estimate | $0.130 |
| EPS actual | $0.0900 |
| EPS surprise | -30.77% |
| Date | Price |
|---|---|
| Feb 11, 2026 | $58.96 |
| Feb 12, 2026 | $57.21 |
| Feb 13, 2026 | $56.58 |
| Feb 17, 2026 | $56.52 |
| Feb 18, 2026 | $50.06 |
| Feb 19, 2026 | $51.76 |
| Feb 20, 2026 | $53.96 |
| Feb 23, 2026 | $53.62 |
| Feb 24, 2026 | $55.24 |
| 4 days before | -15.09% |
| 4 days after | 10.35% |
| On release day | 3.40% |
| Change in period | -6.31% |
| Release date | Apr 29, 2026 |
| Price on release | $66.95 |
| EPS estimate | $0.340 |
| EPS actual | $0.500 |
| EPS surprise | 47.06% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $47.42 |
| Apr 24, 2026 | $50.39 |
| Apr 27, 2026 | $51.61 |
| Apr 28, 2026 | $51.63 |
| Apr 29, 2026 | $66.95 |
| Apr 30, 2026 | $65.99 |
| May 01, 2026 | $66.75 |
| May 04, 2026 | $67.25 |
| May 05, 2026 | $67.79 |
| 4 days before | 41.19% |
| 4 days after | 1.25% |
| On release day | -1.43% |
| Change in period | 42.96% |
| Release date | Jul 23, 2026 |
| Price on release | $69.37 |
| EPS estimate | $0.556 |
| EPS actual | $0.82 |
| EPS surprise | 47.48% |
| Date | Price |
|---|---|
| Jul 17, 2026 | $73.18 |
| Jul 20, 2026 | $73.87 |
| Jul 21, 2026 | $75.89 |
| Jul 22, 2026 | $74.45 |
| Jul 23, 2026 | $69.37 |
| Jul 24, 2026 | $65.97 |
| Jul 27, 2026 | $67.35 |
| Jul 28, 2026 | $69.58 |
| Jul 29, 2026 | $67.54 |
| 4 days before | -5.21% |
| 4 days after | -2.64% |
| On release day | -4.90% |
| Change in period | -7.71% |
The Vita Coco Company Earnings Call Transcript Summary of Q2 2026
Vita Coco reported a strong Q2 2026 with net sales up 28% to $216M, driven by Vita Coco Coconut Water growth (+21%) and a large jump in private label (+83%). Gross profit rose sharply and gross margin expanded to ~49% for the quarter, helped materially by tariff refunds and lower ocean freight. Management closed the acquisition of Copra—a super-premium Nam Hom coconut water manufacturer in Thailand—positioning Vita Coco to compete in the chilled super‑premium segment and to capture private‑label and branded growth in that space. The company raised full‑year guidance: net sales $790M–$805M, full‑year gross margin ~40%, and adjusted EBITDA $154M–$161M. Key risks and near‑term headwinds include rising packaging and domestic logistics costs, recent ocean freight surcharges that will flow into cost of goods in H2, and a temporary production impact from an earthquake in the Philippines (~1% of annual capacity lost). Management is prioritizing capacity expansion for 2028, plans ~$11M CapEx to expand Copra extraction capacity, expects Copra to be accretive to adjusted EBITDA post‑integration, and retains a strong balance sheet ($279M cash, no revolver debt). The board increased buyback authorization (additional $40M approved in July). Overall, management is confident in long‑term category growth and Vita Coco’s positioning, while taking a cautious approach to SG&A and integration costs in the near term.
Sign In
Buy COCO